Sacituzumab Govitecan (Trodelvy)
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Sacituzumab Govitecan (Trodelvy), covering 2025-04-24 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer [Phase 1, Phase 2]